Free Republic

OVAXIN™ is a highly purified and inactivated vaccine that is manufactured using a vero cell manufacturing platform. Immune memory against conserved nucleoprotein may provide an added advantage over spike-only responses Memory T and B cells persisted for at least 6 months post vaccination Data suggest COVAXIN™ (BBV152) may provide protection against current and future variants

<p>Investors looking for exposure to the COVID-19 vaccine market may naturally lean toward Moderna (NASDAQ:MRNA), which developed mRNA-1273, and Pfizer (NYSE:PFE), which developed BNT162b2 in collaboration with BioNTech. These companies were the first to earn Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration for their respective products.</p>